Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-10-11
2005-10-11
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S331000
Reexamination Certificate
active
06953780
ABSTRACT:
The instant invention relates to some tripeptide derivatives having activity against endothelin a process for preparing them, pharmaceutical composition containing the same and their use in prevention or treatment of some diseases associated with endothelin.
REFERENCES:
patent: 5260276 (1993-11-01), Cody et al.
patent: 5691315 (1997-11-01), Ishikawa et al.
patent: 0 548 441 (1993-06-01), None
patent: 7-228594 (1995-08-01), None
Itoh et al. A Novel Endothelin ETA Receptor Antagonist, BQ-485 . . . Biochemical And Biophysical Research Communications. Sep. 15, 1993, vol. 195, No. 2, pp. 969-975.
Spellmeyer et al,Bioorganic Medicinal Chemistry Letters, 3(4):519-524 (1993).
Ding Zhenkai
Liang Yuanjun
Liu Keliang
Wang Hai
Yu Wensheng
Institute of Pharmacology and Toxicology Academy of Military Med
Russel Jeffrey Edwin
LandOfFree
Endothelin antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endothelin antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3490713